These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16892042)

  • 41. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors.
    Yang M; Tang X; Zhang Z; Gu L; Wei H; Zhao S; Zhong K; Mu M; Huang C; Jiang C; Xu J; Guo G; Zhou L; Tong A
    Theranostics; 2020; 10(17):7622-7634. PubMed ID: 32685008
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
    Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
    J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index.
    McDonagh CF; Kim KM; Turcott E; Brown LL; Westendorf L; Feist T; Sussman D; Stone I; Anderson M; Miyamoto J; Lyon R; Alley SC; Gerber HP; Carter PJ
    Mol Cancer Ther; 2008 Sep; 7(9):2913-23. PubMed ID: 18790772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
    Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
    J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
    Welten SP; Redeker A; Franken KL; Benedict CA; Yagita H; Wensveen FM; Borst J; Melief CJ; van Lier RA; van Gisbergen KP; Arens R
    J Virol; 2013 Jun; 87(12):6851-65. PubMed ID: 23576505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
    Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
    Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies.
    Shaffer DR; Savoldo B; Yi Z; Chow KK; Kakarla S; Spencer DM; Dotti G; Wu MF; Liu H; Kenney S; Gottschalk S
    Blood; 2011 Apr; 117(16):4304-14. PubMed ID: 21304103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD70, a novel target of CAR T-cell therapy for gliomas.
    Jin L; Ge H; Long Y; Yang C; Chang YE; Mu L; Sayour EJ; De Leon G; Wang QJ; Yang JC; Kubilis PS; Bao H; Xia S; Lu D; Kong Y; Hu L; Shang Y; Jiang C; Nie J; Li S; Gu Y; Sun J; Mitchell DA; Lin Z; Huang J
    Neuro Oncol; 2018 Jan; 20(1):55-65. PubMed ID: 28651374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.
    Massari F; Santoni M; Ciccarese C; Santini D; Alfieri S; Martignoni G; Brunelli M; Piva F; Berardi R; Montironi R; Porta C; Cascinu S; Tortora G
    Cancer Treat Rev; 2015 Feb; 41(2):114-21. PubMed ID: 25586601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.
    Silence K; Dreier T; Moshir M; Ulrichts P; Gabriels SM; Saunders M; Wajant H; Brouckaert P; Huyghe L; Van Hauwermeiren T; Thibault A; De Haard HJ
    MAbs; 2014; 6(2):523-32. PubMed ID: 24492296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.
    O'Neill RE; Du W; Mohammadpour H; Alqassim E; Qiu J; Chen G; McCarthy PL; Lee KP; Cao X
    J Immunol; 2017 Nov; 199(10):3700-3710. PubMed ID: 29046346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.
    Lee WW; Yang ZZ; Li G; Weyand CM; Goronzy JJ
    J Immunol; 2007 Aug; 179(4):2609-15. PubMed ID: 17675524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4
    Liao W; Li M; Wu H; Jia S; Zhang N; Dai Y; Zhao M; Lu Q
    Clin Epigenetics; 2017; 9():104. PubMed ID: 29018507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses.
    Allam A; Swiecki M; Vermi W; Ashwell JD; Colonna M
    J Immunol; 2014 Jul; 193(2):871-8. PubMed ID: 24913981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
    Tykodi SS; Satoh S; Deming JD; Chou J; Harrop R; Warren EH
    J Immunother; 2012 Sep; 35(7):523-33. PubMed ID: 22892449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
    Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
    J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.